Follow-on roundup: Karuna, CRISPR, Molecular Therapeutics, OptiNose

Since market close on Wednesday, Karuna, CRISPR Therapeutics, Molecular Therapeutics and OptiNose have raised an aggregate of more than $600 million in follow-ons.

Karuna Therapeutics Inc. (NASDAQ:KRTX) raised $250 million late Wednesday through the sale of 2.6 million shares at $96, the same price

Read the full 434 word article

User Sign In